Antibiotice Sa · BVB:ATB

Antibiotice Sa — Investor Presentation (February 2026)

13 slides from Antibiotice Sa's investor presentation, February 2026

  1. Slide 1: 70 years of trust, performance and lasting partnerships

     70 years of trust, performance and lasting partnerships www.antibiotice.ro

  2. Slide 2: Key results recorded in H1 2026

    Write it here Key results recorded in H1 2026 342.3 13.7% +5% Ranked 4th mil lei Gross profit cumulated with the The sales of finished products Consolidated in terms of boxes Total revenue of consumed in the Romanian value of the claw-back tax and active substances were 5% 342.3 million lei. prescri

  3. Slide 3: Antibiotice S.A. - a performance-oriented company

    Write it here Antibiotice S.A. - a performance-oriented company ATB symbol Listing date: April 16, 1997 Market capitalization: 1.45 billion lei* Number of shares: 671,338,040 Other pension funds Privately Administered Funds 9.80% Privately Administered Pension Fund Nominal share value: 0.10 lei/shar

  4. Slide 4: Antibiotice – a company worth working for

    Write it here Antibiotice – a company worth working for Employees with secondary education Highly-educated specialists (54% - 723) (47% - 631) 1,354 EMPLOYEES - Highly-educated specialists Top specializations Employees with secondary pharmaceutical site operator - 41.24% 9.25% education 20.24% econo

  5. Slide 5: Antibiotice – a knowledge- and performance-driven company

    Antibiotice – a knowledge- and performance-driven company Write it here ACADEMIA a+ , a knowledge management platform (staff recruitment and business skills development) TECHNICAL COLLEGE a+ BUSINESS SCHOOL a+ PRE-UNIVERSITY& UNIVERSITY ENVIRONMENT BUSINESS SKILLS DEVELOPMENT ❑ Internships for 178 p

  6. Slide 6: Antibiotice in the service of life for a lifetime

    12 therapeutic classes – 199 products Antibiotice Write it here > 500 marketing authorizations in over 50 countries 38 critical products in the service of life for a lifetime 56 essential products Active Oral Solid Topical Products Sterile Products Substances Products Division Division Division Divi

  7. Slide 7: Antibiotice - a company operating at international standards

    Antibiotice - a company operating at international standards Write it here EU GMP 8 manufacturing flows US FDA Sterile injectable powders and Nystatin, active substance COS (Certificate of Suitability) issued by EDQM Standard și micronized Nystatin ISO TUV RHEINLAND certification for integrated mana

  8. Slide 8: Antibiotice - in the pharmaceutical market in Romania

    Write it here Antibiotice - in the pharmaceutical market in Romania In the HI 2026, on the domestic market, Antibiotice S.A.: mantained its 4th rank (out ranked 1st, as number of of a total of 368 boxes in the total anti- companies) in terms of infectives market (21.7% out consumption (no. of boxes)

  9. Slide 9: Antibiotice – an international brand

    Antibiotice – an international brand Write it here Present in over 50 countries worldwide Europe North America 46% 12.5% Middle East & Africa Asia Pacific 7% 28.5% South America 6% Commercial representations (marketing and sales) Business representatives: North America (USA, Canada) Republic of Mold

  10. Slide 10: Antibiotice - an internationally recognized Romanian brand

    Antibiotice - an internationally recognized Romanian brand Write it here +10% sales growth in Europe Finished products and Nystatin 144.9 mil. lei Europe – the main pillar international turnover International pipeline of internationalization in H1 2026 under development We consolidate our New produc

  11. Slide 11: Write it here

    Write it here Indicators 30 June 2026 30 June 2025 30 June 2026 / 30 June 2025 A. Total revenues, of which: 342.259.104 380.160.338 -9,97% 1. Operating revenues 330.186.451 370.200.532 -10,81% 1.1 Revenue from contracts with customers (revenue), of which: 299.128.061 333.740.008 -10,37% revenue from

  12. Slide 12: H1 2026 Investment Plan Implementation

    Write it here H1 2026 Investment Plan Implementation Total investment: 57.05 mil lei • developing the product portfolio through • adapting the industrial site, utilities in-house research: 9.07 million lei; supply and distribution infrastructures, storage of raw materials and finished • investments

  13. Slide 13: www.antibiotice.ro

    Antibiotice Stiinta si suflet www.antibiotice.ro

Antibiotice — Investor Presentation (February 2026) on 6ix